DKK1 and chronic kidney disease: Although the biological relevance of circulating protein measurements has not been fully elucidated, several clinical studies showed altered sclerostin and DKK-1 concentrations in metabolic bone diseases, in type 1 and 2 diabetes mellitus and in patients with chronic kidney disease (CKD) [31,32,33,34,35].